Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

Insulin elicits a spectrum of biological responses by binding to its cell surface receptor. In a screen for small molecules that activate the human insulin receptor tyrosine kinase, a nonpeptidyl fungal metabolite (L-783,281) was identified that acted as an insulin mimetic in several biochemical and cellular assays. The compound was selective for insulin receptor versus insulin-like growth factor I (IGFI) receptor and other receptor tyrosine kinases. Oral administration of L-783,281 to two mouse models of diabetes resulted in significant lowering in blood glucose levels. These results demonstrate the feasibility of discovering novel insulin receptor activators that may lead to new therapies for diabetes.

[1]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[2]  R. Kendall,et al.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[4]  W. Rutter,et al.  Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Andrius Kazlauskas,et al.  The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.

[6]  R. Roth,et al.  The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. , 1992, The Journal of biological chemistry.

[7]  J. Dixon,et al.  Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[9]  J. Holloszy,et al.  Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. , 1994, Journal of applied physiology.

[10]  J. Berger,et al.  Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. , 1994, The Journal of biological chemistry.

[11]  R. Roth,et al.  Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. , 1990, The Journal of biological chemistry.

[12]  J. Meyerovitch,et al.  Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. , 1987, The Journal of biological chemistry.

[13]  O. Rosen.  Structure and Function of Insulin Receptors , 1989, Diabetes.

[14]  I. Simpson,et al.  Divergent mechanisms for the insulin resistant and hyperresponsive glucose transport in adipose cells from fasted and refed rats. Alterations in both glucose transporter number and intrinsic activity. , 1988, The Journal of clinical investigation.

[15]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.